1) Rehermann B, Ferrari C, Pasquinelli C, et al:The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2:1104-1108,1996
2) Kusumoto S, Tanaka Y, Mizokami M, et al:Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma. Int J Hematol 90:13-23,2009
3) Hui CK, Cheung WW, Zhang HY, et al:Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 131:59-68,2006
4) Yeo W, Chan TC, Leung NW, et al:Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 27:605-611,2009
5) Lok AS, Liang RH, Chiu EK, et al:Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 100:182-188,1991
6) Yeo W, Chan PK, Ho WM, et al:Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. J Clin Oncol 22:927-934,2004
7) Umemura T, Kiyosawa K:Fatal HBV reactivation in a subject with anti-HBs and anti-HBc. Intern Med 45:747-748,2006
8) 坪内博仁,熊田博光,清澤研道,他:免疫抑制・化学療法により発症するB型肝炎対策:厚生労働省「難治性の肝・胆道疾患に関する調査研究」班劇症肝炎分科会および「肝硬変を含めたウイルス性肝疾患の治療の標準化に関する研究」班合同報告.肝臓 50:38-42,2009
9) Yoshida T, Kusumoto S, Inagaki A, et al:Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma:two case reports. Int J Hematol 91:844-849,2010